Theralase Technologies Inc. V.TLT

In the pipeline...

[wildbird1]

Some people on this board did mention that with the large number of pressrelease talking about the impressive number of new applications for TLT compounds, that they were surprised that the SP didn't go up.

Maybe it is because the goal of these Pressrelease was not a short term goal, but instead a long term goal.

With these Pressrelease TLT is preparing the future.
When TLT will finally become a big player in the field of cancer treatments(and they will), big investors will be coming on board. These big investors will want to know what is in the future for TLT. Why?..Because these big investors do not care about short term goals. No! they only care about long terms goals.
When these big investors will start buying, you can bet your shirt that the SP will start a steady climb, and will continue to climb with every new big investors coming on board.

Every big company has a pipeline section, were new investors can see what the future look like.

Judging by the big numbers of new future applications that TLT has, TLT pipeline is already quite impressive.

I love the future of TLT.

[StevenBirch]

Wildbird you have always seen the big picture. Yes the news releases have a de-risking effect and represent future value whereas the PP's determine the current value. So even with the news and the warrant expiry we are mired here until this PP closes, at least, and it will depend on how much they bring in. If there is a sense that this is the last one before BTD is granted then we should see

[wildbird1]

Thanks StevenBirch... -The fact that TLT is preparing for the future is a good indication that TLT management believe they have a great future. -TLT not preparing for the future, would show investors(present and future) a big lack of vision on the part of TLT management. In short...TLT preparing for the future is very reassuring. I love the future of TLT.

[N0taP00p]

Yes, let's all do the feel-good Kumbayah. Who cares about reality.  These same investors just lost 55M warrants based on past projections. Let's just ask them for some more money and hope the Metformin news will do it this time. 

[Mikee3003]

In the pipeline....lol! Get real....bladder is the end game for Theralase. We are either successful with bladder or we go bankrupt. All these woopdie doo news releases of late mean squat and the market agrees! To believe that Theralase will be around in 10 years is just not realistic....swim or sink time people. If we swim with bladder we will be bought out, if we sink........I suppose the kool

[chry200030]

It's one game. They are playing a lot of games...ie.. a lot of irons in the fire. It's all about whether they can finance their game or make a deal somewhere. . 

[CancerSlayer]

The first tranche is in....& my hope is the 2nd (& bigger) tranche will be tied to the BTD milestone.  Smart/more sizeable money has become much more data-driven than before & a BTD should open friendlier doors for either equity or debt financing...imo, the latter being more preferable when we are much closer to the commercial or revenue stage (i.e. post AA).   If there are

[N0taP00p]

@Cancerslayer:  All true, except we don't know how much of a runway they have right now.  If they are still waiting for data to submit pre-BTD and you take in all the waiting time for feedback and approvals, you're looking at 3 months at a minimum for BTD.  I am very sure they'll need money before then and they didn't seem to indicate any progress on other financing

[Longholder99]

I agree Mikee.  If BTD comes through, Theralase will only exist as a subsidiary of a big Pharm but I suspect they will be bought after a series of multi million share buys in a race to see who gets there first, runs us up to the mid teens $. My guess is Merck will make the first move   But others could hamstring Merck with this tech.  All IMO only.  Will be an interesting

[CancerSlayer]

Funding is obviously tough for most small biotechs, many of which raise sufficient money to simply get them through the year or to the next milestone.  However, each milestone warrants a different degree of investor interest/money.  As the study progresses, each successive milestone achieved will generally demand much more interest/friendly funding.  I believe getting to BTD status